AmInvest Research Reports
Stock on Radar - TMC Life Sciences’
AmInvest
Publish date: Wed, 03 Jan 2024, 09:48 AM
AmInvest
0 8,826
An official blog in I3investor to publish research reports provided by AmInvest research team.
All materials published here are prepared by AmInvest. For latest offers on AmInvest trading products and news, please refer to: https://www.aminvest.com/eng/Pages/home.aspx
Tel: +603 2036 1800 / +603 2032 2888
Fax: +603 2031 5210
Email: enquiries@aminvest.com
Office Hours
Monday to Thursday: 8:45am – 5:45pm
Friday: 8:45am – 5:00pm
(GMT +08:00 Malaysia)
All materials published here are prepared by AmInvest. For latest offers on AmInvest trading products and news, please refer to: https://www.aminvest.com/eng/Pages/home.aspx
Tel: +603 2036 1800 / +603 2032 2888
Fax: +603 2031 5210
Email: enquiries@aminvest.com
Office Hours
Monday to Thursday: 8:45am – 5:45pm
Friday: 8:45am – 5:00pm
(GMT +08:00 Malaysia)
TMC Life Sciences’ buying interest is back after it broke out of the 6-week bullish pennant pattern with a long white candle yesterday. As the stock has surged to a new 52-week high, the near term bullish trend may still have legs. A bullish bias may emerge above the RM0.73 level, with a stop-loss set at RM0.66, below the 50-day EMA. Towards the upside, the near-term resistance level is seen at RM0.80, followed by RM0.85.
Entry : RM0.73–0.745
Target : RM0.80, RM0.85
Exit : RM0.66
Source: AmInvest Research - 3 Jan 2024
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
Market Buzz
More articles on AmInvest Research Reports
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Apps
Top Articles
1
The Alpha Trader
2
AnimatedMotion
3
THE INVESTMENT APPROACH OF CALVIN TAN
4
6
7
THE INVESTMENT APPROACH OF CALVIN TAN
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
